182 related articles for article (PubMed ID: 15463889)
1. Eradication of pulmonary methicillin-resistant staphylococcus aureus (MRSA) in cystic fibrosis with linezolid.
Serisier DJ; Jones G; Carroll M
J Cyst Fibros; 2004 Mar; 3(1):61. PubMed ID: 15463889
[No Abstract] [Full Text] [Related]
2. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
Sharpe JN; Shively EH; Polk HC
Am J Surg; 2005 Apr; 189(4):425-8. PubMed ID: 15820454
[TBL] [Abstract][Full Text] [Related]
3. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.
Gales AC; Sader HS; Andrade SS; Lutz L; Machado A; Barth AL
Int J Antimicrob Agents; 2006 Apr; 27(4):300-2. PubMed ID: 16527459
[TBL] [Abstract][Full Text] [Related]
4. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
Kaplan SL; Afghani B; Lopez P; Wu E; Fleishaker D; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S178-85. PubMed ID: 14520144
[TBL] [Abstract][Full Text] [Related]
5. Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid.
Kessler AT; Kourtis AP
Infection; 2007 Jun; 35(4):271-4. PubMed ID: 17646913
[TBL] [Abstract][Full Text] [Related]
6. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
Itani KM; Weigelt J; Li JZ; Duttagupta S
Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
[TBL] [Abstract][Full Text] [Related]
7. Linezolid for tympanostomy tube otorrhea caused by methicillin-resistant Staphylococcus aureus and multiple drug-resistant Streptococcus pneumoniae.
Isaacson G; Aronoff SC
Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):647-51. PubMed ID: 18321598
[TBL] [Abstract][Full Text] [Related]
8. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
De Gascun C; Rajan L; O'Neill E; Smyth EG
J Antimicrob Chemother; 2006 Jan; 57(1):150-1. PubMed ID: 16244085
[No Abstract] [Full Text] [Related]
9. Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection.
Moise PA; Castro RS; Sul C; Forrest A; Sakoulas G
Ann Pharmacother; 2008 Apr; 42(4):592-3. PubMed ID: 18349303
[No Abstract] [Full Text] [Related]
10. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Bassetti M; Di Biagio A; Del Bono V; Cenderello G; Bassetti D
Int J Antimicrob Agents; 2004 Jul; 24(1):83-4. PubMed ID: 15225867
[TBL] [Abstract][Full Text] [Related]
11. Linezolid-resistant Staphylococcus aureus in two pediatric patients receiving low-dose linezolid therapy.
Roberts SM; Freeman AF; Harrington SM; Holland SM; Murray PR; Zelazny AM
Pediatr Infect Dis J; 2006 Jun; 25(6):562-4. PubMed ID: 16732160
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of linezolid in the treatment of mediastinitis due to methicillin-resistant Staphylococcus aureus: an experimental study.
Sacar M; Sacar S; Kaleli I; Cevahir N; Teke Z; Kavas ST; Asan A; Aytekin FO; Baltalarli A; Turgut H
Int J Infect Dis; 2008 Jul; 12(4):396-401. PubMed ID: 18162429
[TBL] [Abstract][Full Text] [Related]
13. Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA).
Bassetti M; Di Biagio A; Cenderello G; Del Bono V; Palermo A; Cruciani M; Bassetti D
J Infect; 2001 Aug; 43(2):148-9. PubMed ID: 11676523
[TBL] [Abstract][Full Text] [Related]
14. Linezolid eradicates MRSA better than vancomycin from surgical-site infections.
Weigelt J; Kaafarani HM; Itani KM; Swanson RN
Am J Surg; 2004 Dec; 188(6):760-6. PubMed ID: 15619496
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of methicillin-resistant Staphylococcus aureus pulmonary infection with linezolid in a patient with cystic fibrosis.
Ferrin M; Zuckerman JB; Meagher A; Blumberg EA
Pediatr Pulmonol; 2002 Mar; 33(3):221-3. PubMed ID: 11836802
[TBL] [Abstract][Full Text] [Related]
16. MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?
Downey DG; Kidd TJ; Coulter C; Bell SC
J Cyst Fibros; 2005 Sep; 4(3):205-7. PubMed ID: 16019268
[TBL] [Abstract][Full Text] [Related]
17. Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial.
Li JZ; Willke RJ; Rittenhouse BE; Rybak MJ
Surg Infect (Larchmt); 2003; 4(1):57-70. PubMed ID: 12744768
[TBL] [Abstract][Full Text] [Related]
18. EUCAST Technical Note on linezolid.
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
Clin Microbiol Infect; 2006 Dec; 12(12):1243-5. PubMed ID: 17121637
[No Abstract] [Full Text] [Related]
19. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis.
Nadesalingam K; Conway SP; Denton M
J Cyst Fibros; 2005 Mar; 4(1):49-52. PubMed ID: 15752681
[TBL] [Abstract][Full Text] [Related]
20. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
